CAS: 1001571-08-9

IMB5046 is a cytotoxic drug that has potent cytotoxicity and can be used in cancer therapy. It is a nitrobenzoate derivative that inhibits the activity of multidrug resistant cells. IMB5046 has been shown to inhibit the growth of cancer cells, including breast, prostate, lung, colon and lymphoma cell lines, as well as drug-resistant cells. The effectiveness of this drug may be due to its ability to inhibit cellular proliferation by affecting DNA synthesis and cell division.